Human medicines European public assessment report (EPAR): Rezurock, belumosudil, Date of authorisation: 24/03/2026, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 April 2026 - 9:20

Human medicines European public assessment report (EPAR): Rezurock, belumosudil, Date of authorisation: 24/03/2026, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rezurock

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters